Oxidative stress and baroreflex sensitivity in healthy subjects and patients with mild-to-moderate hypertension

被引:0
|
作者
O Ormezzano
J-L Cracowski
J-P Baguet
P François
J Bessard
G Bessard
J-M Mallion
机构
[1] Grenoble University Hospital,Cardiology Department
[2] Laboratory of Pharmacology HP2,Public Health Department
[3] Grenoble School of Medicine,undefined
[4] Grenoble University Hospital,undefined
来源
关键词
isoprostane; lipid peroxidation; oxidative stress baroreflex;
D O I
暂无
中图分类号
学科分类号
摘要
Decreased baroreflex sensitivity (BRS) is a prognostic marker in essential hypertension. Animal experiments suggest that decreased BRS is related to increased oxidative stress. Our study was aimed at testing whether oxidative stress, estimated by isoprostane 15-F2t-IsoP urinary levels, is correlated to BRS variation in healthy subjects as well as in patients suffering from essential hypertension. Urinary 15-F2t-IsoP levels and BRS were evaluated in two groups of subjects: healthy volunteers (n=64) and patients with untreated mild-to-moderate hypertension (n=33). Data were analysed in 61 and 31 subjects, respectively, BRS analysis being impossible in three and two subjects, respectively. 15-F2t-IsoP levels were measured using gas chromatography/mass spectrometry. BRS was measured using the sequence method [PS+/RR+ and PS−/RR−] and crossspectral analysis (CSP) (MF gain) at rest, lying down. No significant correlation was found between basal urinary 15-F2t-IsoP levels and BRS (sequence method and CSP) in either healthy controls or hypertensive patients. Our study shows that oxidative stress is not involved in interindividual variations of BRS in healthy subjects and patients suffering from mild-to-moderate hypertension
引用
收藏
页码:517 / 521
页数:4
相关论文
共 50 条
  • [21] ISRADIPINE IN THE TREATMENT OF MILD-TO-MODERATE HYPERTENSION IN GERIATRIC-PATIENTS
    ROCHAGONCALVES, F
    MOURA, B
    PEREIRAMIGUEL, JM
    CORREANUNES, A
    MARIANOPEGO, G
    AMERICAN JOURNAL OF HYPERTENSION, 1994, 7 (07) : S64 - S66
  • [22] The efficacy of telmisartan compared with perindopril in patients with mild-to-moderate hypertension
    Nalbantgil, I
    Nalbantgil, S
    Özerkan, F
    Yilmaz, H
    Gürgün, C
    Zoghi, M
    Aytimur, M
    Önder, R
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 : 50 - 54
  • [23] ABPM comparison of telmisartan and valsartan in patients with mild-to-moderate hypertension
    Littlejohn, TW
    JOURNAL OF HYPERTENSION, 2000, 18 : S97 - S97
  • [24] Cardiac remodelling and functional alterations in mild-to-moderate renal dysfunction: comparison with healthy subjects
    Asp, Anna M.
    Wallquist, Carin
    Rickenlund, Anette
    Hylander, Britta
    Jacobson, Stefan H.
    Caidahl, Kenneth
    Eriksson, Maria J.
    CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2015, 35 (03) : 223 - 230
  • [25] ISRADIPINE IN THE TREATMENT OF MILD-TO-MODERATE HYPERTENSION IN PORTUGAL
    PEREIRAMIGUEL, JM
    CORREANUNES, A
    ROCHAGONCALVES, F
    MARIANOPEGO, G
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 : S49 - S52
  • [26] AN ASSESSMENT OF LACIDIPINE AND ATENOLOL IN MILD-TO-MODERATE HYPERTENSION
    LYONS, D
    FOWLER, G
    WEBSTER, J
    HALL, ST
    PETRIE, JC
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 37 (01) : 45 - 51
  • [27] Efficacy and safety of spirapril in mild-to-moderate hypertension
    Hayduk, K
    Kraul, H
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1999, 34 : S19 - S23
  • [28] GUANFACINE - AN AGENT EFFECTIVE FOR MILD-TO-MODERATE HYPERTENSION
    OWEN, JA
    HOSPITAL FORMULARY, 1983, 18 (09): : 851 - &
  • [29] HOSTILITY AND THE RESPONSE TO DIURETIC IN MILD-TO-MODERATE HYPERTENSION
    PASIC, J
    SHAPIRO, D
    JAMNER, LD
    HUI, KK
    AMERICAN JOURNAL OF HYPERTENSION, 1994, 7 (06) : 503 - 508
  • [30] RENAL EFFECTS OF NICARDIPINE IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION
    BABA, T
    BOKU, A
    ISHIZAKI, T
    SONE, K
    TAKEBE, K
    AMERICAN HEART JOURNAL, 1986, 111 (03) : 552 - 557